Tensive's REGENERA™ implant shows positive 12-month data for natural breast reconstruction after lumpectomy

Tensive S.r.l., a medical device company, reported positive interim 12-month follow-up data from its pivotal trial of the REGENERA™ implant for breast reconstruction after lumpectomy. The bioresorbable scaffold demonstrated a favorable safety profile, high surgeon satisfaction, and durable, good-to-excellent cosmetic outcomes, with sustained improvements in patient-reported quality of life and no interference with oncologic follow-up.